JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1988; 12:140-149
© 1988 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Borggrefe, M
Right arrow Articles by Breithardt, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Borggrefe, M
Right arrow Articles by Breithardt, G

Reappraisal of criteria for assessing drug efficacy in patients with ventricular tachyarrhythmias: complete versus partial suppression of inducible arrhythmias

M Borggrefe, HJ Trampisch, and G Breithardt

Hospital of the University of Dusseldorf, Department of Cardiology, Pneumology and Angiology, West Germany.

To test whether increased difficulty in inducing ventricular tachycardia during antiarrhythmic therapy can be considered a sufficient criterion for predicting long-term efficacy of such therapy in patients with ventricular tachyarrhythmias, 95 patients were studied with a graded stimulation protocol (single and double premature stimuli during sinus rhythm and ventricular drives of 120, 140, 160 and 180 beats/min). After a control study, the effects of oral antiarrhythmic drugs on the ability to induce ventricular tachycardia were assessed. The median number of drug trials was four per patient. After antiarrhythmic therapy, four subgroups of patients were identified. In 36 patients, there was no change in inducibility (group 1), whereas in 18 patients ventricular tachycardia was rendered more difficult to induce; that is, a sustained ventricular tachycardia was inducible at a basic drive at least 40 beats/min faster than during the control study (group 2). In 34 patients, ventricular tachycardia induction was suppressed (group 3) and in 7 patients with nonsustained ventricular tachycardia, only 3 to 5 repetitive ventricular responses were induced after treatment (group 4). During follow-up of 15.5 +/- 11.5 months, 10 patients of group 1 had a recurrence of ventricular tachycardia and 6 died suddenly, whereas in group 2 only 1 patient died suddenly and in group 3, 2 patients had a recurrence of ventricular tachycardia (group 1 versus 2 and 3, p less than 0.001, Mantel-Cox and Breslow; group 2 versus 3, no difference). Thus, increased difficulty in inducing ventricular tachycardia is a sufficient criterion for predicting long-term efficacy of an antiarrhythmic drug regimen.


This article has been cited by other articles:


Home page
EuropaceHome page
D. Bansch, H. Kottkamp, G. Gronefeld, J. Vogt, C. Israel, D. Bocker, G. Hindricks, K.-H. Kuck, and on behalf of the Quick-ICD investigators
The quick-implantable-defibrillator trial
Europace, December 1, 2007; 9(12): 1144 - 1150.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. L. Lee, G. Hafley, J. D. Fisher, M. R. Gold, E. N. Prystowsky, M. Talajic, M. E. Josephson, D. L. Packer, A. E. Buxton, and for the Multicenter Unsustained Tachycardia Trial
Effect of Implantable Defibrillators on Arrhythmic Events and Mortality in the Multicenter Unsustained Tachycardia Trial
Circulation, July 9, 2002; 106(2): 233 - 238.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. Bansch, M. Castrucci, D. Bocker, G.u. Breithardt, and M. Block
Ventricular tachycardias above the initially programmed tachycardia detection interval in patients with implantable cardioverter-defibrillators: Incidence, prediction and significance
J. Am. Coll. Cardiol., August 1, 2000; 36(2): 557 - 565.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. Bansch, D. Bocker, J.u. Brunn, M. Weber, G.u. Breithardt, and M. Block
Clusters of ventricular tachycardias signify impaired survival in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillators
J. Am. Coll. Cardiol., August 1, 2000; 36(2): 566 - 573.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Martinez-Rubio, Y. Schwammenthal, E. Schwammenthal, M. Block, L. Reinhardt, A. Garcia-Alberola, G. Sierra, M. Shenasa, W. Haverkamp, H. H. Scheld, et al.
Patients With Valvular Heart Disease Presenting With Sustained Ventricular Tachyarrhythmias or Syncope : Results of Programmed Ventricular Stimulation and Long-term Follow-up
Circulation, July 15, 1997; 96(2): 500 - 508.
[Abstract] [Full Text]


Home page
CirculationHome page
D. Bocker, W. Haverkamp, M. Block, M. Borggrefe, D. Hammel, and G. Breithardt
Comparison of d,l-Sotalol and Implantable Defibrillators for Treatment of Sustained Ventricular Tachycardia or Fibrillation in Patients With Coronary Artery Disease
Circulation, July 15, 1996; 94(2): 151 - 157.
[Abstract] [Full Text]


Home page
CirculationHome page
A. Garcia-Alberola, S. Yli-Mayry, M. Block, W. Haverkamp, A. Martinez-Rubio, H. Kottkamp, G. Breithardt, and M. Borggrefe
RR Interval Variability in Irregular Monomorphic Ventricular Tachycardia and Atrial Fibrillation
Circulation, January 15, 1996; 93(2): 295 - 300.
[Abstract] [Full Text]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1988 by the American College of Cardiology Foundation.